Rufus Mitchell-Heggs

1 episode · 1 moment · last on 3 Apr 2026

3 Apr 2026OpenAI $852B, Legora $100M ARR, SpaxeX IPO, April Fools Award

2:41:408 min

Brain Tracking Go-To-Market: Regulation, Clinics and Roadmap

On rolling the product out, the team describes two regulatory buckets — wellness, with no diagnostic claims, GDPR-compliant data practices and CE-marked devices, and clinical — plus quick-to-set-up hardware that can run in clinics or pop-up settings. Go-to-market aims to make brain tracking as habitual as tracking sleep or steps. The next six months center on peer-reviewed metrics from continuous studies with Imperial College London and an inference model, launching with the announcement, that links lifestyle factors to brain metrics.